MOFCOM trials IP guideline for Chinese enterprises doing business overseas
By Yi Yi Wu
The Ministry of Commerce (MOFCOM) issued the Guideline on Overseas Intellectual Property Rights for Enterprises for trial implementation on 8 February 2014. The guideline aims to encourage Chinese enterprises to proactively protect their rights by providing greater protection for intellectual property rights (IPRs) for overseas investments and through mechanisms designed to promptly resolve intellectual property (IP) disputes. The guideline focuses on the creation, usage, protection and management of IPRs, the establishment of a sound IP management and incentive system and a practical IP strategy for overseas investments. The information mainly focuses on six areas of IPR, including patents, trademarks, copyright and infringements.
We have reviewed the guideline to identify the main focus areas and the key points of advice to consider…
Click on the link below to read the rest of the Minter Ellison briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Minter Ellison
News from The Lawyer
Briefings from Minter Ellison
Asia Region Funds Passport: draft rules a step towards a regional market for managed investment funds
The Asia Region Funds Passport will create a regional market for managed investment funds and give Australian fund managers an opportunity to increase their presence in Asia.
The Federal Court of Australia has dismissed the ACCC’s anti-competitive conduct case against Pfizer, finding that Pfizer did not breach the prohibition on misuse of market power.